Rare diseases
Investigational molecules
Locations
6401 Hollis Street Suite 125, 94608-1462, United States
Santen Inc. is engaged in clinical research focused on Fuchs endothelial corneal dystrophy, a degenerative disorder of the corneal endothelium that affects vision and corneal clarity.
The sponsor’s research activity reflects a therapeutic interest in conditions that impair corneal function and visual performance.
Santen Inc. runs clinical trials in conditions such as Corneal dystrophy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
